A bench of Justices Vikram Nath and Sandeep Mehta took note of the Centre's decision to impose a 30 per cent cap on trade margins for specified cancer drugs but sought to know why similar scrutiny could not extend to other medicines.
A bench of Justices Vikram Nath and Sandeep Mehta took note of the Centre's decision to impose a 30 per cent cap on trade margins for specified cancer drugs but sought to know why similar scrutiny could not extend to other medicines.
<iframe src="https://hindustansphere.com/embed/cluster/f3f2a3a51460b6fc1515dd5c03cd70843eb15f98" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="'Why only cancer drugs?': SC questions Centre on trade margin cap, seeks wider price regulation"></iframe>
A bench of Justices Vikram Nath and Sandeep Mehta took note of the Centre's decision to impose a 30 per cent cap on trade margins for specified cancer drugs but sought to know why similar scrutiny could not extend to other medicines.
